Fig. 2
From: A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae
Percentage of participants reporting symptoms between 25 and > 175 days post infection. a 25–89 days (N = 56), b 90–174 days (N = 55), and c greater than 175 days (N = 42). The number of participants in the surveys vary for each time point. d Percentage of participants who suffered mild (N = 43), moderate (N = 13), or severe (N = 16) COVID-19, reporting symptoms at any follow-up visit (from days 20–243 post infection)